Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0.02%1.75T | 0.24%7.16T | 2.39%1.75T | 11.61%7.14T | 1.37%1.79T | 13.98%1.84T | 12.18%1.8T | 21.05%1.71T | 16.06%6.4T | 17.20%1.77T |
| Cost of revenue | 0.43%1.51T | 0.07%6.06T | 1.16%1.5T | 10.28%6.05T | 0.99%1.5T | 11.97%1.54T | 10.22%1.53T | 19.62%1.48T | 16.46%5.49T | 15.04%1.49T |
| Gross profit | -2.43%245.69B | 1.18%1.1T | 10.45%251.81B | 19.62%1.09T | 3.40%289.34B | 25.63%298.57B | 24.56%274.05B | 31.29%227.99B | 13.68%911.14B | 30.22%279.82B |
| Operating expense | 5.52%138.49B | -17.68%583.91B | -1.77%131.25B | 46.24%709.35B | 21.08%147.32B | 117.24%271.82B | 22.11%156.61B | 21.46%133.61B | 5.37%485.05B | -6.39%121.67B |
| Selling and administrative expenses | 3.88%138.88B | -15.45%604.67B | 1.50%133.68B | 45.82%715.16B | 19.39%148.98B | 120.89%276.15B | 26.60%158.33B | 13.95%131.71B | 6.52%490.45B | 5.15%124.79B |
| -General and administrative expense | 3.88%138.88B | -15.45%604.67B | 1.50%133.68B | 45.82%715.16B | 19.39%148.98B | 120.89%276.15B | 26.60%158.33B | 13.95%131.71B | 6.52%490.45B | 5.15%124.79B |
| Other operating expenses | 2.58%4.81B | -2.12%42.76B | -17.04%4.69B | 36.74%43.69B | 75.97%20.16B | 154.26%10.87B | -39.13%7B | 19.88%5.66B | -18.12%31.95B | -42.11%11.46B |
| Total other operating income | -27.02%5.2B | 28.33%63.52B | 89.88%7.13B | 32.49%49.5B | 49.71%21.82B | 264.54%15.21B | 4.87%8.72B | -63.55%3.75B | -4.60%37.36B | 71.45%14.58B |
| Operating profit | -11.08%107.21B | 36.35%518.95B | 27.75%120.57B | -10.68%380.6B | -10.20%142.02B | -76.22%26.76B | 27.97%117.44B | 48.29%94.38B | 24.89%426.1B | 86.27%158.15B |
| Net non-operating interest income (expenses) | 4.90%29.23B | 7.25%60.56B | 20.49%27.86B | 49.31%56.47B | 5,265.05%9.98B | 22.35%20.83B | 34.29%2.53B | 23.52%23.13B | 11.72%37.82B | -20.17%186M |
| Non-operating interest income | -4.12%34.23B | 9.73%86.37B | 24.63%35.7B | 52.89%78.71B | 202.64%12.14B | 34.56%29.37B | 107.26%8.56B | 33.12%28.64B | 21.84%51.48B | 39.31%4.01B |
| Non-operating interest expense | -36.21%5B | 16.02%25.81B | 41.99%7.83B | 62.78%22.25B | -43.47%2.16B | 77.88%8.53B | 168.30%6.03B | 97.42%5.52B | 62.63%13.67B | 44.54%3.83B |
| Net investment income | 131.91%3.93B | 40.63%-10.51B | -487.75%-12.31B | -329.96%-17.69B | -446.44%-9.58B | -229.76%-8.15B | 20.43%-3.14B | 791.72%3.18B | -202.39%-4.12B | 17.36%2.77B |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | -108.52%-136M | -46.64%9B | -81.41%1.6B | 675.44%16.87B | 313.62%5.1B | 284.45%1.61B | 196.85%1.57B | 1,205.62%8.59B | -150.89%-2.93B | -408.80%-2.39B |
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 1.82%140.23B | 32.50%578.01B | 6.54%137.72B | -4.52%436.24B | -7.05%147.52B | -67.81%41.05B | 34.42%118.39B | 56.57%129.27B | 18.73%456.87B | 79.81%158.72B |
| Income tax | 43.88%51.36B | 39.77%112.75B | -2.27%35.7B | -26.00%80.66B | -104.58%-1.26B | -27.67%19.86B | 0.19%25.54B | 27.49%36.53B | 13.49%109.01B | 146.46%27.42B |
| Net income | -12.89%88.87B | 30.85%465.26B | 10.00%102.02B | 2.22%355.57B | 13.31%148.78B | -78.82%21.19B | 48.35%92.86B | 72.02%92.74B | 20.47%347.86B | 70.20%131.3B |
| Net income continuous operations | -12.89%88.87B | 30.85%465.26B | 10.00%102.02B | 2.22%355.57B | 13.31%148.78B | -78.82%21.19B | 48.35%92.86B | 72.02%92.74B | 20.47%347.86B | 70.20%131.3B |
| Noncontrolling interests | 26.92%9.6B | 7.93%46.18B | 3.83%7.56B | 28.75%42.78B | -19.76%11.61B | 80.02%14.5B | 8.36%9.4B | 257.18%7.28B | 33.70%33.23B | 119.00%14.47B |
| Net income attributable to the company | -16.08%79.27B | 33.98%419.08B | 10.53%94.46B | -0.59%312.79B | 17.41%137.17B | -92.72%6.7B | 54.78%83.46B | 64.74%85.46B | 19.22%314.63B | 65.63%116.83B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -16.08%79.27B | 33.98%419.08B | 10.53%94.46B | -0.59%312.79B | 17.41%137.17B | -92.72%6.7B | 54.78%83.46B | 64.74%85.46B | 19.22%314.63B | 65.63%116.83B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -12.17%28.5 | 38.15%145.02 | 13.73%32.45 | 0.93%104.97 | 19.31%46.33 | -92.68%2.24 | 57.49%6.965 | 67.94%28.5325 | 21.36%104 | 68.28%38.83 |
| Diluted earnings per share | -12.17%28.5 | 38.15%145.02 | 13.73%32.45 | 0.93%104.97 | 19.31%46.33 | -92.68%2.24 | 57.49%6.965 | 67.94%28.5325 | 21.36%104 | 68.28%38.83 |
| Dividend per share | 0 | 16.36%64 | 0 | 18.92%55 | 26.32%30 | 0 | 11.11%25 | 0 | 19.35%46.25 | 11.76%23.75 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |